NGLY1 deficiency: Novel variants and literature review.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 01 08 2020
revised: 05 12 2020
accepted: 20 01 2021
pubmed: 27 1 2021
medline: 6 7 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

NGLY1 deficiency is a recently described autosomal recessive disorder, involved in deglycosylation of proteins, and for that reason grouped as the congenital disorders of deglycosylation together with the lysosomal storage disorders. The typical phenotype is characterized by intellectual disability, liver malfunctioning, muscular hypotonia, involuntary movements, and decreased or absent tear production. Liver biopsy demonstrates vacuolar amorphous cytoplasmic storage material. NGLY1 deficiency is caused by bi-allelic variants in NGLY1 which catalyzes protein deglycosylation. We describe five patients from two families with NGLY1 deficiency due to homozygosity for two novel NGLY1 variants, and compare their findings to those of earlier reported patients. The typical features of the disorder are present in a limited way, and there is intra-familial variability. In addition in one of the families the muscle atrophy and posture abnormalities are marked. These can be explained either as variability of the phenotype or as sign of slowly progression of features as the present affected individuals are older than earlier reported patients.

Identifiants

pubmed: 33497766
pii: S1769-7212(21)00012-4
doi: 10.1016/j.ejmg.2021.104146
pii:
doi:

Substances chimiques

NGLY1 protein, human EC 3.5.1.52
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase EC 3.5.1.52

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104146

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Ariana Kariminejad (A)

Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran. Electronic address: arianakariminejad@yahoo.com.

Marjan Shakiba (M)

Pediatric Endocrinology and Metabolism Department, Mofid Children Hospital, Shahid Beheshti, University of Medical Science, Tehran, Iran.

Mehrvash Shams (M)

Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran.

Parva Namiranian (P)

Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran.

Maryam Eghbali (M)

Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: eghbalim@almnus.tums.a.cir.

Said Talebi (S)

Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. Electronic address: talebi.s@iums.ac.ir.

Mina Makvand (M)

Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran.

Jaak Jaeken (J)

Department of Development and Regeneration, Center for Metabolic Diseases, KU Leuven, Leuven, Belgium.

Hossein Najmabadi (H)

Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Raoul C Hennekam (RC)

Department of Pediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH